Market Place
Sourcing Support
Crown Bioscience Expands Singapore Facility With New Capabilities
01 Oct 2024 //
BUSINESSWIRE
JSR Life Sciences Announces Operational Consolidation of KBI Bio and Selexis
31 May 2023 //
BUSINESSWIRE
Crown Bioscience Opens Singapore Lab, Partners with JSR Life Sciences
10 Mar 2023 //
CONTRACT PHARMA
Similis Bio Partners With Novel351k to Develop Multiple Biosimilar Programs
15 Feb 2023 //
CONTRACT PHARMA
Crown Bioscience inks deal with ERS for gene editing technology
12 Dec 2022 //
FIERCEBIOTECH
JSR Life Sciences Launches `Similis Bio` for Biosimilar Development
10 May 2022 //
BUSINESSWIRE
JSR Life Sciences Appoints Mark W. Womack to Lead KBI Biopharma and Selexis SA
02 May 2022 //
BUSINESSWIRE
KBI Biopharma Opens New Commercial Manufacturing Facility
21 Apr 2022 //
CONTRACTPHARMA
JSR Life Sciences’ Amsphere A3 Leveraged in FDA-Approved Antibody Therapy
21 Mar 2022 //
CONTRACTPHARMA
Hemogenyx, Selexis Will Advance AML CDX Bispecific Antibody to Human Trials
12 Jan 2022 //
BUSINESSWIRE
Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’
07 Oct 2021 //
BUSINESSWIRE
JSR Life Sciences Unveils Corporate Venture Fund
24 Mar 2021 //
CONTRACTPHARMA
JSR Life Sciences Launches Corporate Venture Fund to Foster Investment
23 Mar 2021 //
BUSINESSWIRE
CrownBio and JSR Life Sciences Partner with Quantum
24 Feb 2021 //
BUSINESSWIRE
Crown Biosciences Opens Facility in China
04 Nov 2020 //
CONTRACTPHARMA
JSR Life Sciences Expands European Footprint
21 Oct 2020 //
CONTRACTPHARMA
JSR Life Sciences Expands European Footprint
20 Oct 2020 //
CONTRACTPHARMA
JSR Life Sciences Expands Its European Gene-to-GMP Biologics MFG Facilities
20 Oct 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.